Roessner A - Search Results

1

p16INK4A alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas.

Semczuk A, Boltze C, Marzec B, Szczygielska A, Roessner A, Schneider-Stock R. Semczuk A, et al. Among authors: roessner a. J Cancer Res Clin Oncol. 2003 Oct;129(10):589-96. doi: 10.1007/s00432-003-0482-2. Epub 2003 Aug 14. J Cancer Res Clin Oncol. 2003. PMID: 12920579

2

Allelic loss at TP53 is not related to p53 protein overexpression in primary human endometrial carcinomas.

Semczuk A, Marzec B, Skomra D, Roessner A, Cybulski M, Rechberger T, Schneider-Stock R. Semczuk A, et al. Among authors: roessner a. Oncology. 2005;69(4):317-25. doi: 10.1159/000089764. Epub 2005 Nov 17. Oncology. 2005. PMID: 16293976

3

P16 alterations increase the metastatic potential of endometrial carcinoma.

Ignatov A, Bischoff J, Schwarzenau C, Krebs T, Kuester D, Herrmann K, Costa SD, Roessner A, Semczuk A, Schneider-Stock R. Ignatov A, et al. Among authors: roessner a. Gynecol Oncol. 2008 Nov;111(2):365-71. doi: 10.1016/j.ygyno.2008.07.037. Epub 2008 Sep 14. Gynecol Oncol. 2008. PMID: 18790522

4

Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer.

Semczuk A, Marzec B, Roessner A, Jakowicki JA, Wojcierowski J, Schneider-Stock R. Semczuk A, et al. Among authors: roessner a. Virchows Arch. 2002 Dec;441(6):577-83. doi: 10.1007/s00428-002-0695-9. Epub 2002 Sep 25. Virchows Arch. 2002. PMID: 12461615

5

RB protein expression in human endometrial carcinomas--an immunohistochemical study.

Semczuk A, Schneider-Stock R, Miturski R, Skomra D, Tomaszewski J, Roessner A, Jakowicki JA. Semczuk A, et al. Among authors: roessner a. Pathol Res Pract. 2000;196(1):41-6. doi: 10.1016/S0344-0338(00)80020-5. Pathol Res Pract. 2000. PMID: 10674271

6

K-ras exon 2 point mutations in human endometrial cancer.

Semczuk A, Schneider-Stock R, Berbec H, Marzec B, Jakowicki JA, Roessner A. Semczuk A, et al. Among authors: roessner a. Cancer Lett. 2001 Mar 26;164(2):207-12. doi: 10.1016/s0304-3835(01)00380-9. Cancer Lett. 2001. PMID: 11179836

7

Hypermethylation of the CDKN2/p16INK4A promotor in thyroid carcinogenesis.

Boltze C, Zack S, Quednow C, Bettge S, Roessner A, Schneider-Stock R. Boltze C, et al. Among authors: roessner a. Pathol Res Pract. 2003;199(6):399-404. doi: 10.1078/0344-0338-00436. Pathol Res Pract. 2003. PMID: 12924440

8

Differences in loss of p16INK4 protein expression by promoter methylation between left- and right-sided primary colorectal carcinomas.

Schneider-Stock R, Boltze C, Peters B, Höpfner T, Meyer F, Lippert H, Roessner A. Schneider-Stock R, et al. Among authors: roessner a. Int J Oncol. 2003 Oct;23(4):1009-13. Int J Oncol. 2003. PMID: 12963980

9

P53/MDM2 overexpression in metastatic endometrial cancer: correlation with clinicopathological features and patient outcome.

Jeczen R, Skomra D, Cybulski M, Schneider-Stock R, Szewczuk W, Roessner A, Rechberger T, Semczuk A. Jeczen R, et al. Among authors: roessner a. Clin Exp Metastasis. 2007;24(7):503-11. doi: 10.1007/s10585-007-9087-5. Epub 2007 Aug 2. Clin Exp Metastasis. 2007. PMID: 17671841

10

Allelic loss at TP53 in metastatic human endometrial carcinomas.

Szewczuk W, Skomra D, Cybulski M, Przadka-Rabaniuk D, Filip A, Jóźwik M, Olcha P, Roessner A, Semczuk A. Szewczuk W, et al. Among authors: roessner a. Clin Exp Metastasis. 2009;26(7):789-96. doi: 10.1007/s10585-009-9278-3. Epub 2009 Jun 30. Clin Exp Metastasis. 2009. PMID: 19565339

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

494 results

Search Page

Filters